Name:
Haloxazolam
Type:
Benzodiazepine
AKA:
N/A
Haloxazolam image
Synthetic substance, no natural derivative
IUPAC Logo
Haloxazolam image
Haloxazolam, a thienodiazepine, was first developed in the 1980s. It was introduced for its anxiolytic and sedative effects, similar to benzodiazepines. Haloxazolam's use has been associated with dependence and regulatory controls due to its potential for abuse.
Synthetic Substances Image
Haloxazolam is a benzodiazepine that provides anxiolytic and sedative effects. It causes drowsiness, reduced heart rate, and muscle relaxation. Short-term use effectively manages anxiety, but long-term use may result in dependence and cognitive issues. Overdose risks include severe sedation and respiratory depression. Safe use requires careful dosing and monitoring. Recent research emphasizes its benefits in anxiety treatment and potential for misuse.
N/A
A benzodiazepine with anxiolytic and sedative effects. Long-term use can cause dependence, cognitive decline, and mood disorders. Research indicates its impact on GABAergic systems and associated psychological risks.
N/A
Haloxazolam is a benzodiazepine used for its sedative and anxiolytic effects. The history of benzodiazepines includes their development for treating anxiety, insomnia, and other conditions. Haloxazolam's cultural significance is tied to the broader narrative of mental health treatment and the evolving understanding of anxiety disorders. The use of benzodiazepines is often debated, with discussions about their benefits, risks, and potential for dependence. Media coverage frequently highlights personal experiences with these medications, contributing to ongoing conversations about mental health care, the ethics of pharmaceutical treatment, and the pursuit of safer therapeutic options.
N/A